Showing 4,901 - 4,920 results of 107,033 for search '(( 50 ((mean decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( a we decrease ))', query time: 1.38s Refine Results
  1. 4901
  2. 4902

    Table1_The Activation of Protamine 1 Using Epigenome Editing Decreases the Proliferation of Tumorigenic Cells.XLSX by Hadjer Namous (3908641)

    Published 2022
    “…PRM1 expression resulted in a significant decrease in cell proliferation as measured by the BrdU ELISA assay. …”
  3. 4903

    Table2_The Activation of Protamine 1 Using Epigenome Editing Decreases the Proliferation of Tumorigenic Cells.DOCX by Hadjer Namous (3908641)

    Published 2022
    “…PRM1 expression resulted in a significant decrease in cell proliferation as measured by the BrdU ELISA assay. …”
  4. 4904
  5. 4905
  6. 4906
  7. 4907
  8. 4908
  9. 4909

    FOXO1-mediated Downregulation of RAB27B Leads to Decreased Exosome Secretion in Diabetic Kidneys by Mengru Zeng (10119544)

    Published 2021
    “…Here, we have verified the decrease of exosome secretion in DKD and unveiled the underlying mechanism. …”
  10. 4910
  11. 4911
  12. 4912
  13. 4913

    Treatment outcomes. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  14. 4914

    Quality assessment of included papers. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  15. 4915

    Basic characteristics of the included studies. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  16. 4916

    SHARP1 Suppresses Angiogenesis of Endometrial Cancer by Decreasing Hypoxia-Inducible Factor-1α Level by Yun Liao (160524)

    Published 2014
    “…Overexpression of SHARP1 in vivo inhibited tumor growth and angiogenesis, and decreased HIF-1α expression. In this study, we established SHARP1 as a novel tumor suppressor of EC and shed light on the mechanisms by how SHARP1 inhibited EC progression. …”
  17. 4917

    Supplementary Material for: Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer by Izawa N. (6834062)

    Published 2019
    “…<b><i>Objectives:</i></b> This study aimed to evaluate whether a decrease of computed tomography (CT) value for tumors serves as a predictive marker in patients with advanced gastric cancer (aGC) who have undergone chemotherapy with vascular epithelial growth factor receptor 2 inhibitor (ramucirumab). …”
  18. 4918
  19. 4919
  20. 4920